跳至主要内容
临床试验/CTRI/2022/07/044015
CTRI/2022/07/044015招募中不适用

Comparative Clinical Evaluation of Pippalyadi Churna and Bhumyamlaki Churna in Shweta-Pradara (Leucorrhoea)

Rishikul Campus Uttarkhand Ayurveda University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年7月15日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60
试验地点
1
主要终点
To evaluate the comparative effect of Pippalyadi Churna and Bhumyamalaki Churna in Shweta-Pradara (leucorrhoea). subjectively all signs and symptoms are given with grading depending upon there severity.

研究概览

简要总结

Shweta-Pradara is a type of abnormal vaginal discharge. it can be correlated with Leucorrhoea in modern science. This study trial drug Pippalyadi churna and Bhumyamalaki churna to evaluate their comparative effects in Shweta Pradara. Pippalyadi Churna and Bhumyamalaki Churna will be given orally to the patient for 15 days . Duration of treatment is 30 days.  patient will be taken from OPD No 9 PG Department of Prasuti Tantra Evam Stree Roga, Rishikul Campus Haridwar, Uttarakhand Ayurved University Harrawala, Dehradun

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
16.00 Year(s) 至 48.00 Year(s)(—)
性别
Female

入选标准

  • Female patients of Age between 16 to 45 years.
  • Unmarried/Married Females.
  • Pratyatama Lakshanas of Shwetapradara (Cardinal feature of white discharge).

排除标准

  • Female of age group below 16 years and above 45 years.
  • Patients those having bleeding disorders.

结局指标

主要结局

To evaluate the comparative effect of Pippalyadi Churna and Bhumyamalaki Churna in Shweta-Pradara (leucorrhoea). subjectively all signs and symptoms are given with grading depending upon there severity.

时间窗: 15 days

次要结局

  • Exacerbation in sign and symptoms(15 days)

研究者

发起方
Rishikul Campus Uttarkhand Ayurveda University
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验